(Q33684389)

28 July 2017

1 reference

title

Risk for posttransplant Diabetes mellitus with current immunosuppressive medications (English)

1 reference

28 July 2017

Weir MR

1

1 reference

28 July 2017

Fink JC

series ordinal

2

1 reference

28 July 2017

language of work or name

1 reference

1 July 1999

1 reference

American Journal of Kidney Diseases

28 July 2017

published in

1 reference

28 July 2017

volume

34

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

1-13

1 reference

The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Cyclosporine's effect on insulin secretion in patients with kidney transplants.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Posttransplant diabetes in kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Diabetes mellitus after renal transplantation in the cyclosporine era--an analysis of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Some Characteristics of Steroid Diabetes: A Study in Renal-Transplant Recipients Receiving High-Dose Corticosteroid Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

HLA-A28 and steroid-induced diabetes in renal transplant patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Association of HLA Antigens with Glucose Intolerance Following Renal Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Pittsburgh Epidemiology of Diabetes Complications Study-V

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Advantages of low dose steroid from the day after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Reduction of toxicity of corticosteroid therapy after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Alternate-day prednisone therapy in recipients of renal allografts. Risk and benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Effects of steroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Glucocorticoid Inhibition of Glucose Uptake by Peripheral Tissues: Old and New Evidence, Molecular Mechanisms, and Physiological Significance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Alterations in Insulin Binding Induced by Changes in Vivo in the Levels of Glucocorticoids and Growth Hormone*

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Inhibitory Effect of Prednisone on Insulin Secretion in Man: Model for Duplication of Blood Glucose Concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Glycosuria and hyperglycaemia after kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Post-transplant diabetes mellitus in renal allograft recipients: a matched-pair control study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Effects of cyclosporin on prednisolone metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Intravenous glucose tolerance and pancreatic islet beta-cell function in patients with multiple sclerosis during 2-yr treatment with cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Recovery and hypersecretion of insulin and reversal of insulin resistance after withdrawal of short-term cyclosporine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Toxic effects of cyclosporine on the endocrine pancreas of Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Reversibility of the acute toxic effect of cyclosporin A on pancreatic B cells of Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Role of cyclosporin A in macromolecular synthesis of beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Long-term effects of cyclosporin A on cultured mouse pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Cyclosporin-induced inhibition of insulin secretion in isolated rat islets and HIT cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Possible role for calmodulin in insulin release. Studies with trifluoperazine in rat pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Effects of cyclosporine on glucose tolerance in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Direct effects of cyclosporin A on human pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Synthesis-secretion coupling of insulin. Effect of cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Inhibition by cyclosporine of insulin secretion--a beta cell-specific alteration of islet tissue function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Liver, kidney, and thoracic organ transplantation under FK 506.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Insulin requirements after liver transplantation and FK-506 immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Morphological and functional changes of islets of Langerhans in FK506-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Effect of FK506 on insulin secretion in normal dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

In vivo effect of FK506 on human pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

RS-61443--a phase I clinical trial and pilot rescue study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

The efficacy and toxicity of rapamycin in murine islet transplantation. In vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970101-0

7 January 2021

10.1016/S0272-6386(99)70101-0

Identifiers

DOI

1 reference

28 July 2017

1 reference